BioCentury
ARTICLE | Company News

Genome Therapeutics and SGP name asthma gene

February 21, 2001 8:00 AM UTC

GENE received a milestone payment from Schering-Plough (SGP) under the companies' collaboration to identify a susceptibility gene for asthma (see BioCentury, Jan. 6, 1997). Under the agreement, GENE ...